GO
Loading...

Biogen Idec Inc

More

  • Stop Trading!: A Starbucks Comeback? Friday, 1 Aug 2008 | 3:23 PM ET

    This coffee giant looks a lot like McDonald's before it turned up, Cramer says.

  • Stocks Retreat After ISM, Jobs Reports Friday, 1 Aug 2008 | 12:31 PM ET

    Stocks got a quick pop from the better-than-expected July jobs report but the gains faded within the first 10 minutes of trading.

  • So Much For The Summer Doldrums Friday, 1 Aug 2008 | 11:14 AM ET

    What a crazy week, right? Monday, Amgen had a huge upside revenue and earnings surprise. Tuesday, the Food and Drug Administration issued its new restrictions on the use of Amgen's anemia drugs in certain cancer patients. Later that same day, Elan and Wyeth released the big Alzheimer's drug test results.

  • Stocks Pull Back After Initial Jobs Pop Friday, 1 Aug 2008 | 9:56 AM ET

    Stocks got a quick pop from the better-than-expected July jobs report but the gains faded within the first 10 minutes of trading.

  • GM's Loss: Not A Record But Hardly Trivial Friday, 1 Aug 2008 | 9:13 AM ET

    Significant losses in GM North America, the strike at American Axle, and continued losses at GMAC Financial were just a few of the problems. They say they have access to $26 billion in liquidity, and insist that they have enough liquidity to last through 2009.

  • Elan Shares Plunge 50%, Biogen Tumbles in Germany Friday, 1 Aug 2008 | 8:35 AM ET

    Shares in Irish drugmaker Elan dived more than 50 percent to their lowest level since 2005 on Friday as a second product setback in a week shattered confidence in its line-up of biotech medicines.

  • Biogen, Elan Stocks Tank on Problems With Tysabri Thursday, 31 Jul 2008 | 6:30 PM ET

    Biogen Idec and Elan notified regulators of two confirmed cases of a potentially deadly brain disease in multiple sclerosis (MS) patients being treated with Tysabri.

  • Breaking News: Drug Danger Thursday, 31 Jul 2008 | 6:22 PM ET

    Biogen Idec and Elan said on Thursday they have notified regulators of two confirmed cases of a potentially deadly brain disease in multiple sclerosis (MS) patients being treated with Tysabri.

  • Whale Watching: Carl Icahn Tuesday, 29 Jul 2008 | 6:31 PM ET

    In all the seven seas, there is no bigger whale than Carl Icahn. Should you trade in his wake?

  • Election-Year Trades: Health Care Monday, 28 Jul 2008 | 5:53 PM ET

    Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.

  • Pipeline Of Profits! Monday, 28 Jul 2008 | 4:00 PM ET

    Pete Najarian reveals 3 biotechs he feels provide the most bang for the buck?

  • The Latest Picks That Paid – Friday July 25th Friday, 25 Jul 2008 | 7:18 PM ET
    Quicker Ticker

    Our traders are good - but you knew that! Check out their latest picks that paid.

  • Pops & Drops: AIG, Hasbro... Monday, 21 Jul 2008 | 6:44 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of AIG and Biogen popped while Hasbro and CME Group dropped.

  • The buyout offer from Swiss drug giant Roche has shares of DNA trading at their highest level in about two-and-a-half years and according to CNBC stock-stat maven, Robert Hum, if they close up at least 8.88% it'll be their biggest one-day percentage gain since April 15, 2005.

  • Bear Market Band-Aid Tuesday, 15 Jul 2008 | 6:26 PM ET

    You’ve gotta’ love modern medicine. Not only does it cure stomach upset now it may be the best remedy for what ails your portfolio.

  • Oil Drops, Stocks Pop Tuesday, 8 Jul 2008 | 5:51 PM ET

    The Dow rose Tuesday in another turbulent session after a pullback in oil prices eased worries about consumer and business spending. What's the "Word on the Street?"

  • Pfizer and the State of Statins Monday, 23 Jun 2008 | 11:15 AM ET

    As much as I tried to disconnect during my vacation last week, I couldn't escape the ubiquitous presence of pharmaceuticals in our everyday lives...

  • Icahn Finally Adopts His Own Web Strategy Thursday, 19 Jun 2008 | 3:59 PM ET
    Carl Icahn

    Corporate raider Carl Icahn has had much to say about Yahoo's internal machinations and its refusal to submit to the hostile overtures of Microsoft. He's had much to say about the company's planned partnership with Google, which surprisingly, seemed a little more positive than many experts had anticipated.

  • High oil prices and a wary skittishness among traders keeps the pressure on stocks going into Thursday's session. Weekly jobless data, reported at 8:30am ET, is the big number ahead of Thursday's bell. The Philadelphia Fed survey and leading indicators are released at 10am.

  • Market Insider: Thursday Look Ahead Wednesday, 18 Jun 2008 | 8:02 PM ET

    High oil prices and a wary skittishness among traders keeps the pressure on stocks going into Thursday's session.